541 related articles for article (PubMed ID: 17110117)
1. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
2. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
4. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
[TBL] [Abstract][Full Text] [Related]
5. New tyrosinase inhibitors selected by atomic linear indices-based classification models.
Casañola-Martín GM; Khan MT; Marrero-Ponce Y; Ather A; Sultankhodzhaev MN; Torrens F
Bioorg Med Chem Lett; 2006 Jan; 16(2):324-30. PubMed ID: 16275084
[TBL] [Abstract][Full Text] [Related]
6. Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation.
Casañola-Martin GM; Marrero-Ponce Y; Khan MT; Khan SB; Torrens F; Pérez-Jiménez F; Rescigno A; Abad C
Chem Biol Drug Des; 2010 Dec; 76(6):538-45. PubMed ID: 20964806
[TBL] [Abstract][Full Text] [Related]
7. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.
Casañola-Martín GM; Marrero-Ponce Y; Tareq Hassan Khan M; Torrens F; Pérez-Giménez F; Rescigno A
J Biomol Screen; 2008 Dec; 13(10):1014-24. PubMed ID: 19015291
[TBL] [Abstract][Full Text] [Related]
8. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
[TBL] [Abstract][Full Text] [Related]
9. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
Marrero-Ponce Y; Khan MT; Casañola-Martín GM; Ather A; Sultankhodzhaev MN; García-Domenech R; Torrens F; Rotondo R
J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
[TBL] [Abstract][Full Text] [Related]
10. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
[TBL] [Abstract][Full Text] [Related]
11. Antiprotozoan lead discovery by aligning dry and wet screening: prediction, synthesis, and biological assay of novel quinoxalinones.
Martins Alho MA; Marrero-Ponce Y; Barigye SJ; Meneses-Marcel A; Machado Tugores Y; Montero-Torres A; Gómez-Barrio A; Nogal JJ; García-Sánchez RN; Vega MC; Rolón M; Martínez-Fernández AR; Escario JA; Pérez-Giménez F; Garcia-Domenech R; Rivera N; Mondragón R; Mondragón M; Ibarra-Velarde F; Lopez-Arencibia A; Martín-Navarro C; Lorenzo-Morales J; Cabrera-Serra MG; Piñero J; Tytgat J; Chicharro R; Arán VJ
Bioorg Med Chem; 2014 Mar; 22(5):1568-85. PubMed ID: 24513185
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
Marrero-Ponce Y; Siverio-Mota D; Gálvez-Llompart M; Recio MC; Giner RM; García-Domènech R; Torrens F; Arán VJ; Cordero-Maldonado ML; Esguera CV; de Witte PA; Crawford AD
Eur J Med Chem; 2011 Dec; 46(12):5736-53. PubMed ID: 22000935
[TBL] [Abstract][Full Text] [Related]
13. New antitrichomonal drug-like chemicals selected by bond (edge)-based TOMOCOMD-CARDD descriptors.
Meneses-Marcel A; Rivera-Borroto OM; Marrero-Ponce Y; Montero A; Machado Tugores Y; Escario JA; Gómez Barrio A; Montero Pereira D; Nogal JJ; Kouznetsov VV; Ochoa Puentes C; Bohórquez AR; Grau R; Torrens F; Ibarra-Velarde F; Arán VJ
J Biomol Screen; 2008 Sep; 13(8):785-94. PubMed ID: 18753687
[TBL] [Abstract][Full Text] [Related]
14. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
Castillo-Garit JA; Vega MC; Rolon M; Marrero-Ponce Y; Kouznetsov VV; Torres DF; Gómez-Barrio A; Bello AA; Montero A; Torrens F; Pérez-Giménez F
Eur J Pharm Sci; 2010 Jan; 39(1-3):30-6. PubMed ID: 19854271
[TBL] [Abstract][Full Text] [Related]
15. Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds.
Montero-Torres A; García-Sánchez RN; Marrero-Ponce Y; Machado-Tugores Y; Nogal-Ruiz JJ; Martínez-Fernández AR; Arán VJ; Ochoa C; Meneses-Marcel A; Torrens F
Eur J Med Chem; 2006 Apr; 41(4):483-93. PubMed ID: 16545891
[TBL] [Abstract][Full Text] [Related]
16. Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity.
Marrero-Ponce Y; Medina-Marrero R; Torrens F; Martinez Y; Romero-Zaldivar V; Castro EA
Bioorg Med Chem; 2005 Apr; 13(8):2881-99. PubMed ID: 15781398
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Jun N; Hong G; Jun K
Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
[TBL] [Abstract][Full Text] [Related]
18. Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix': application to 'in silico' studies for the rational discovery of new antimalarial compounds.
Marrero-Ponce Y; Montero-Torres A; Zaldivar CR; Veitía MI; Peréz MM; Sánchez RN
Bioorg Med Chem; 2005 Feb; 13(4):1293-304. PubMed ID: 15670938
[TBL] [Abstract][Full Text] [Related]
19. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.
Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F
J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375
[TBL] [Abstract][Full Text] [Related]
20. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
Marrero-Ponce Y
J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
